keyword
https://read.qxmd.com/read/38698627/enhancement-of-frozen-thawed-human-sperm-quality-with-zinc-as-a-cryoprotective-additive
#21
JOURNAL ARTICLE
Longlong Fu, Jing Ma, Lixia Chen, Ying Guo, Wenjie Li, Xingguo Zhang, Wenhong Lu, Shusong Wang, Ying Liu
BACKGROUND Cryopreservation preserves male fertility, crucial in oncology, advanced age, and infertility. However, it damages sperm motility, membrane, and DNA. Zinc (Zn), an antioxidant, shows promise in improving sperm quality after thawing, highlighting its potential as a cryoprotectant in reproductive medicine. MATERIAL AND METHODS Gradient concentration of ZnSO₄ (0, 12.5, 25, 50, and 100 µM) was added in the Glycerol-egg yolk-citrate (GEYC) cryopreservative medium as an extender. Alterations in sperm viability and motility parameters after cryopreservation were detected in each group...
May 3, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/38698609/renal-angiomyolipoma-selective-arterial-embolization-australian-tertiary-centre-experience-over-10%C3%A2-years
#22
JOURNAL ARTICLE
Paul Siasat, Jack Griffin, Ashu Jhamb, Dan Lenaghan, Cosmin Florescu
INTRODUCTION: The purpose of this study is to evaluate the patient selection methods, treatment outcomes, complications, clinical and radiological follow-up after renal angiomyolipoma (AML) treatment with selective arterial embolization (SAE) in an Australian metropolitan tertiary centre. METHODS: This study presents a retrospective single-centre review of patients' medical records who underwent SAE for renal AML during the period of 1st January 2012 and 1st January 2023...
May 2, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38698577/radiation-therapy-for-ventricular-arrhythmias
#23
REVIEW
Xingzhou Liulu, Poornima Balaji, Jeffrey Barber, Kasun De Silva, Tiarne Murray, Andrew Hickey, Timothy Campbell, Jill Harris, Harriet Gee, Verity Ahern, Saurabh Kumar, Eric Hau, Pierre C Qian
Ventricular arrhythmias (VA) can be life-threatening arrhythmias that result in significant morbidity and mortality. Catheter ablation (CA) is an invasive treatment modality that can be effective in the treatment of VA where medications fail. Recurrence occurs commonly following CA due to an inability to deliver lesions of adequate depth to cauterise the electrical circuits that drive VA or reach areas of scar responsible for VA. Stereotactic body radiotherapy is a non-invasive treatment modality that allows volumetric delivery of energy to treat circuits that cannot be reached by CA...
May 2, 2024: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/38698538/high-throughput-molecular-assays-for-inclusion-in-personalised-oncology-trials-state-of-the-art-and-beyond
#24
JOURNAL ARTICLE
Anders Edsjö, Hege G Russnes, Janne Lehtiö, David Tamborero, Eivind Hovig, Albrecht Stenzinger, Richard Rosenquist
In the last decades, the development of high-throughput molecular assays has revolutionised cancer diagnostics, paving the way for the concept of personalised cancer medicine. This progress has been driven by the introduction of such technologies through biomarker-driven oncology trials. In this review, strengths and limitations of various state-of-the-art sequencing technologies, including gene panel sequencing (DNA and RNA), whole-exome/whole-genome sequencing and whole-transcriptome sequencing, are explored, focusing on their ability to identify clinically relevant biomarkers with diagnostic, prognostic and/or predictive impact...
May 2, 2024: Journal of Internal Medicine
https://read.qxmd.com/read/38698477/three-dimensional-printed-custom-made-modular-talus-prosthesis-in-patients-with-talus-malignant-tumor-resection
#25
JOURNAL ARTICLE
Xuanhong He, Minxun Lu, Chang Zou, Zhuangzhuang Li, Taojun Gong, Guy Romeo Kenmegne, Yitian Wang, Yi Luo, Yong Zhou, Li Min, Chongqi Tu
BACKGROUND: Talar malignant tumor is extremely rare. Currently, there are several alternative management options for talus malignant tumor including below-knee amputation, tibio-calcaneal arthrodesis, and homogenous bone transplant while their shortcomings limited the clinical application. Three-dimensional (3D) printed total talus prosthesis in talus lesion was reported as a useful method to reconstruct talus, however, most researches are case reports and its clinical effect remains unclear...
May 2, 2024: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/38698475/metabolic-dysfunction-associated-fatty-liver-disease-increases-the-risk-of-complications-after-radical-resection-in-patients-with-hepatocellular-carcinoma
#26
JOURNAL ARTICLE
Ke-Gong Xiong, Kun-Yu Ke, Jin-Feng Kong, Tai-Shun Lin, Qing-Biao Lin, Su Lin, Yue-Yong Zhu
BACKGROUND AND AIMS: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) in hepatocellular carcinoma (HCC) patients is increasing, yet its association with postoperative complications of HCC remains unclear. The aim of this study was to investigate the impact of MAFLD on complications after radical resection in HCC patients. METHODS: Patients with HCC who underwent radical resection were included. Patients were stratified into MAFLD group and non-MAFLD group...
May 3, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38698468/cxcr6-positive-circulating-mucosal-associated-invariant-t-cells-can-identify-patients-with-non-small-cell-lung-cancer-responding-to-anti-pd-1-immunotherapy
#27
JOURNAL ARTICLE
Jingjing Qu, Binggen Wu, Lijun Chen, Zuoshi Wen, Liangjie Fang, Jing Zheng, Qian Shen, Jianfu Heng, Jianya Zhou, Jianying Zhou
BACKGROUND: Mucosal-associated invariant T (MAIT) cells have been reported to regulate tumor immunity. However, the immune characteristics of MAIT cells in non-small cell lung cancer (NSCLC) and their correlation with the treatment efficacy of immune checkpoint inhibitors (ICIs) remain unclear. PATIENTS AND METHODS: In this study, we performed single-cell RNA sequencing (scRNA-seq), flow cytometry, and multiplex immunofluorescence assays to determine the proportion and characteristics of CD8+MAIT cells in patients with metastatic NSCLC who did and did not respond to anti-PD-1 therapy...
May 3, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38698462/ficolin-3-promotes-ferroptosis-in-hcc-by-downregulating-ir-srebp-axis-mediated-mufa-synthesis
#28
JOURNAL ARTICLE
Yanmei Yuan, Junting Xu, Quanxin Jiang, Chuanxin Yang, Ning Wang, Xiaolong Liu, Hai-Long Piao, Sijia Lu, Xianjing Zhang, Liu Han, Zhiyan Liu, Jiabin Cai, Fang Liu, Suzhen Chen, Junli Liu
BACKGROUND: Targeting ferroptosis has been identified as a promising approach for the development of cancer therapies. Monounsaturated fatty acid (MUFA) is a type of lipid that plays a crucial role in inhibiting ferroptosis. Ficolin 3 (FCN3) is a component of the complement system, serving as a recognition molecule against pathogens in the lectin pathway. Recent studies have reported that FCN3 demonstrates inhibitory effects on the progression of certain tumors. However, whether FCN3 can modulate lipid metabolism and ferroptosis remains largely unknown...
May 3, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38698446/colorectal-carcinoma-peritoneal-metastases-derived-organoids-results-and-perspective-of-a-model-for-tailoring-hyperthermic-intraperitoneal-chemotherapy-from-bench-to-bedside
#29
JOURNAL ARTICLE
Luca Varinelli, Davide Battistessa, Marcello Guaglio, Susanna Zanutto, Oscar Illescas, Ewelina J Lorenc, Federica Pisati, Shigeki Kusamura, Laura Cattaneo, Giovanna Sabella, Massimo Milione, Alessia Perbellini, Sara Noci, Cinzia Paolino, Elisabetta Khun, Margherita Galassi, Tommaso Cavalleri, Marcello Deraco, Manuela Gariboldi, Dario Baratti
BACKGROUND: Peritoneal metastases from colorectal cancer (CRCPM) are related to poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been reported to improve survival, but peritoneal recurrence rates are still high and there is no consensus on the drug of choice for HIPEC. The aim of this study was to use patient derived organoids (PDO) to build a relevant CRCPM model to improve HIPEC efficacy in a comprehensive bench-to-bedside strategy...
May 2, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38697713/epidemiological-clinical-therapeutic-and-evolutionary-specificities-of-the-association-between-venous-thromboembolic-event-and-cancer-in-sub-saharan-africa-case-of-togo
#30
JOURNAL ARTICLE
Y M Afassinou, A A Adani-Ifè, Y I Sossou, S Pessinaba, B Atta, M Pio, S Baragou, F Damorou
BACKGROUND: Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources. MATERIALS AND METHODS: This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined medical records of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed...
April 2024: Journal de Médecine Vasculaire
https://read.qxmd.com/read/38697585/cyclodextrin-encapsulation-enabling-the-anticancer-repositioning-of-disulfiram-preparation-analytical-and-in-vitro-biological-characterization-of-the-inclusion-complexes
#31
JOURNAL ARTICLE
Beáta-Mária Benkő, Gergő Tóth, Dorottya Moldvai, Szabina Kádár, Edina Szabó, Zoltán-István Szabó, Márta Kraszni, Lajos Szente, Béla Fiser, Anna Sebestyén, Romána Zelkó, István Sebe
Drug repositioning is a high-priority and feasible strategy in the field of oncology research, where the unmet medical needs are continuously unbalanced. Disulfiram is a potential non-chemotherapeutic, adjuvant anticancer agent. However, the clinical translation is limited by the drug's poor bioavailability. Therefore, the molecular encapsulation of disulfiram with cyclodextrins is evaluated to enhance the solubility and stability of the drug. The present work describes for the first time the complexation of disulfiram with randomly methylated-β-cyclodextrin...
April 30, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38697471/quality-assured-analysis-of-pik3ca-mutations-in-hr-her2-breast-cancer-tissue-a-story-about-the-need-for-proficiency-testing-for-high-quality-molecular-biomarker-reporting-in-precision-medicine
#32
JOURNAL ARTICLE
Carolin Schmidt, Robert Stöhr, Lora Dimitrova, Matthias W Beckmann, Matthias Rübner, Peter A Fasching, Carsten Denkert, Ulrich Lehmann, Claudia Vollbrecht, Florian Haller, Arndt Hartmann, Ramona Erber
In precision oncology, reliable testing of predictive molecular biomarkers is the prerequisite for optimal patient treatment. Interlaboratory comparisons are a crucial tool to verify diagnostic performance and reproducibility of one's approach. Here, we describe the design and results of the first recurrent, internationally performed PIK3CA Breast Cancer Tissue external quality assessment (EQA), which was organized by German Quality in Pathology (QuIP) GmbH and started in 2021. After the internal pretesting phase performed by the (lead) panel institutes, in both 2021 and 2022, each EQA test set comprised n=10 tissue samples of hormone receptor-positive, human epidermal growth factor receptor 2-negative invasive breast cancer (IBC) that had to be analyzed and reported by the participants...
April 30, 2024: Journal of Molecular Diagnostics: JMD
https://read.qxmd.com/read/38696264/tregs-protect-against-combination-checkpoint-blockade-toxicity-induced-by-tph-and-b-cell-interactions
#33
JOURNAL ARTICLE
Alyssa Duffy, Maryam I Azeem, Smriti Kanangat, Melinda Yushak, David Lawson, Madhav V Dhodapkar, Kavita M Dhodapkar
No abstract text is available yet for this article.
May 2, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38696248/it-related-barriers-and-facilitators-to-the-implementation-of-a-new-european-ehealth-solution-the-digital-survivorship-passport-surpass-version-2-0-semistructured-digital-survey
#34
JOURNAL ARTICLE
Ismay A E de Beijer, Selina R van den Oever, Eliana Charalambous, Giorgio Cangioli, Julia Balaguer, Edit Bardi, Marie Alfes, Adela Cañete Nieto, Marisa Correcher, Tiago Pinto da Costa, Alexander Degelsegger-Márquez, Vanessa Düster, Anna-Liesa Filbert, Desiree Grabow, Gerald Gredinger, Hannah Gsell, Riccardo Haupt, Maria van Helvoirt, Ruth Ladenstein, Thorsten Langer, Anja Laschkolnig, Monica Muraca, Saskia M F Pluijm, Jelena Rascon, Günter Schreier, Zuzana Tomášikova, Florian Trauner, Justas Trinkūnas, Kathrin Trunner, Anne Uyttebroeck, Leontien C M Kremer, Helena J H van der Pal, Catherine Chronaki
BACKGROUND: To overcome knowledge gaps and optimize long-term follow-up (LTFU) care for childhood cancer survivors, the concept of the Survivorship Passport (SurPass) has been invented. Within the European PanCareSurPass project, the semiautomated and interoperable SurPass (version 2.0) will be optimized, implemented, and evaluated at 6 LTFU care centers representing 6 European countries and 3 distinct health system scenarios: (1) national electronic health information systems (EHISs) in Austria and Lithuania, (2) regional or local EHISs in Italy and Spain, and (3) cancer registries or hospital-based EHISs in Belgium and Germany...
May 2, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38696053/therapeutic-use-of-granulocyte-colony-stimulating-factor-g-csf-in-patients-with-febrile-neutropenia-a-comprehensive-systematic-review-for-clinical-practice-guidelines-for-the-use-of-g-csf-2022-from-the-japan-society-of-clinical-oncology
#35
JOURNAL ARTICLE
Kenji Tsuchihashi, Mamoru Ito, Yuta Okumura, Kenta Nio, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, Dai Maruyama, Tetsuhiro Yoshinami, Nobuyuki Susumu, Munetaka Takekuma, Takashi Motohashi, Nobuaki Ochi, Toshio Kubo, Keita Uchino, Takahiro Kimura, Yutaro Kamiyama, Shinji Nakao, Shinobu Tamura, Hitomi Nishimoto, Yasuhisa Kato, Atsushi Sato, Toshimi Takano, Eishi Baba
BACKGROUND: Febrile neutropenia represents a critical oncologic emergency, and its management is pivotal in cancer therapy. In several guidelines, the use of granulocyte colony-stimulating factor (G-CSF) in patients with chemotherapy-induced febrile neutropenia is not routinely recommended except in high-risk cases. The Japan Society of Clinical Oncology has updated its clinical practice guidelines for the use of G-CSF, incorporating a systematic review to address this clinical question...
May 2, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38696052/prognostic-value-of-a-mandibular-canal-staging-system-for-primary-lesions-in-patients-with-lower-gingival-squamous-cell-carcinoma-a-multicenter-retrospective-study
#36
JOURNAL ARTICLE
Nobuhiro Yamakawa, Masaya Okura, Takumi Hasegawa, Mitsunobu Otsuru, Hironori Sakai, Eiji Hirai, Shin Rin, Shin-Ichi Yamada, Souichi Yanamoto, Yusuke Yokota, Masahiro Umeda, Hiroshi Kurita, Michihiro Ueda, Masaya Akashi, Tadaaki Kirita
BACKGROUND: The Union for International Cancer Control and American Joint Committee on Cancer tumor staging system is used globally for treatment planning. As it may be insufficient for tumor staging of lower gingival carcinomas, we proposed the mandibular canal tumor staging system. In this study, we aimed to compare the two systems for such tumor staging and to identify prognostic markers. METHODS: This multicenter, retrospective study included patients with lower gingival squamous cell carcinoma who underwent radical surgery during 2001-2018...
May 2, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38695995/car-t-cell-therapy-in-pancreatic-and-biliary-tract-cancers-an-updated-review-of-clinical-trials
#37
REVIEW
Konstantinos Drougkas, Konstantinos Karampinos, Ioannis Karavolias, Georgia Gomatou, Ioannis-Alexios Koumprentziotis, Ioanna Ploumaki, Efthymios Triantafyllou, Elias Kotteas
BACKGROUND: Pancreatic and biliary tract cancers are digestive system tumors with dismal prognosis and limited treatment options. The effectiveness of conventional surgical interventions, radiation therapy, and systemic therapy is restricted in these cases. Furthermore, clinical trials have shown that immunotherapy using immune checkpoint inhibitors has only demonstrated modest clinical results when applied to patients with pancreatobiliary tumors. This highlights the importance of implementing combination immunotherapy approaches or exploring alternative therapeutic strategies to improve treatment outcomes...
May 2, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38695944/primary-lung-cancer-in-children-and-adolescents
#38
JOURNAL ARTICLE
Qiuming Chen, Jun Cheng, Luming Wang, Xiayi Lv, Jian Hu
PURPOSE: Primary lung cancer is extremely rare in children and adolescents. The aim of this study is to clarify clinical features and outcomes of primary lung cancer in children and adolescents. METHODS: Young patients (aged ≤ 20 years) diagnosed as primary lung cancer between 2012 and 2023 were retrospective reviewed. According to radiological appearance of the nodules, they were divided into solid nodule (SN) group and ground glass opacity (GGO) group...
May 2, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38695773/young-adult-cancer-survivors-perspectives-on-cancer-s-impact-on-different-life-areas-post-treatment-a-qualitative-study
#39
JOURNAL ARTICLE
Hannah Arem, Danielle A Duarte, Benjamin White, Katie Vinson, Pamela Hinds, Nathan Ball, Kyla Dennis, Darcey M McCready, Lauren A Cafferty, Carla J Berg
Purpose: Young adult cancer survivors experience disruptions in various life domains (e.g., relationships, academic/career) during and after treatment. This study examined life disruptions and related supports to update interventions to improve psychological outcomes. Methods: In April-July 2023, young adult survivors ( n = 23) were recruited (via clinics, support groups, nonprofit organizations, etc.) to complete semi-structured interviews assessing cancer's impact across life domains, how they coped with related disruptions, and facilitators to improved psychosocial well-being...
May 2, 2024: Journal of Adolescent and Young Adult Oncology
https://read.qxmd.com/read/38695241/decoding-long-non%C3%A2-coding-rnas-friends-and-foes-in-cancer-development-review
#40
REVIEW
Hequn Song, Joseph Adu-Amankwaah, Qizhong Zhao, Dongqi Yang, Kuntao Liu, Aisha Bushi, Jinming Zhao, Jinxiang Yuan, Rubin Tan
Cancer remains a formidable adversary, challenging medical advancements with its dismal prognosis, low cure rates and high mortality rates. Within this intricate landscape, long non‑coding RNAs (lncRNAs) emerge as pivotal players, orchestrating proliferation and migration of cancer cells. Harnessing the potential of lncRNAs as therapeutic targets and prognostic markers holds immense promise. The present comprehensive review delved into the molecular mechanisms underlying the involvement of lncRNAs in the onset and progression of the top five types of cancer...
June 2024: International Journal of Oncology
keyword
keyword
27183
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.